At a glance
ClinicalIndex Comparison RecordN/ACompleted· 140 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Trials to Evaluate the Association Between the Results of Specific Genetic Tests and the Efficacy of Targeted Therapies in Patients With Non-small Cell Lung Cancer
In Brief
An observational study for Non-small Cell Lung Cancer. Completed, enrolled 140 participants across 1 site.
Detailed Summary
Our study aimed to evaluate the correlation between test reagent specific gene test results and the efficacy of relevant targeted drugs in patients with non-small cell lung cancer, and to support the continued registration of test reagents.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsNon-small Cell Lung Cancer
CountriesChina
Collaborators--
Timeline
N/ACompletedFinished
2023202420252026
Enrollment StartJun 2022
First PostedJul 2022
Primary CompletionMar 2023
Study CompletionOct 2023
TodayJul 2026
First PostedJul 8, 2022
Enrollment StartJun 30, 2022
Primary CompletionMar 31, 2023
Study CompletionOct 1, 2023
TodayJul 1, 2026
Enrollment to primary: 9 monthsPosted 4.0 years ago